
Delivering next-gen biomanufacturing capability
Washington DC (SPX) Aug 26, 2021 - Slow production methods and reliance on a global supply chain currently limit DoD access to critical proteins such as medical countermeasures (MCMs) (i.e. antibodies, vaccines, and clotting factors)














